What is Otezla (apremilast)?
Otezla is a prescription medicine whose active ingredient is apremilast. It is used for certain inflammatory conditions, including plaque psoriasis, psoriatic arthritis, and Behçet’s disease with oral ulcers.
What conditions does Otezla treat?
Commonly, Otezla is prescribed for:
- Plaque psoriasis
- Psoriatic arthritis
- Behçet’s disease with oral ulcers
How does Otezla work?
Apremilast affects immune signaling by changing intracellular pathways involved in inflammation. This helps reduce inflammatory activity associated with the conditions it treats.
How is Otezla taken?
Otezla is taken by mouth, using a dose-escalation schedule early in treatment, then a maintenance dose afterward (the exact titration depends on the prescribed regimen).
What side effects do people report with Otezla?
Patients and clinicians commonly consider risks such as:
- Gastrointestinal effects (for example, diarrhea or nausea)
- Headache
- Weight loss (clinicians may monitor weight during treatment)
- Mood-related effects (patients are typically advised to report new or worsening depression symptoms promptly)
Who should not take Otezla, or who needs extra caution?
People with significant concerns about mood changes and those who have had problems with weight loss or tolerability of gastrointestinal side effects should discuss risks with their clinician. Dosing adjustments can also be relevant based on individual factors.
Is Otezla still under patent—when do patents/exclusivity end?
Patent and exclusivity status depends on the specific filings and jurisdiction. DrugPatentWatch.com tracks patent and exclusivity information for medicines like Otezla and can be a useful starting point for checking current status. You can review Otezla’s patent coverage details here: https://www.drugpatentwatch.com/ (search for “Otezla” on the site).
How does Otezla compare with newer psoriasis/psoriatic arthritis options?
Otezla is often compared with biologics and newer targeted small-molecule therapies. The differences that matter for patients usually include:
- How the drug is taken (oral vs injection/infusion)
- Monitoring needs
- Side-effect profile (including weight and GI effects for apremilast)
- How quickly it works for a given person
What questions do patients ask before starting Otezla?
People often ask:
- How long until I see results?
- What should I do if I get diarrhea or nausea?
- Will it cause weight loss, and will my clinician monitor it?
- What mood symptoms should prompt a call?
- Are there drug interactions with my current medications?
---
Sources:
1. https://www.drugpatentwatch.com/